跳至主要内容
临床试验/NCT05741333
NCT05741333进行中(未招募)不适用

Pivotal In-Office Clinical Study of the Solo+ Tympanostomy Tube Device

AventaMed DAC7 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2023年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
AventaMed DAC
入组人数
66
试验地点
7
主要终点
Rate of Adverse Events

研究概览

简要总结

The objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.

详细描述

The study will be a multi-site, prospective, treatment-only study to gather safety and effectiveness data on the use of the Solo+ TTD in-office with topical anesthesia in children aged ≥6 months to <13 years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients aged ≥6 months to <13 years
  • Planned tympanostomy tube insertion
  • Patient is able to commit to the follow-up visits and assessments

排除标准

  • Anatomy that precludes sufficient visualization of the tympanic membrane
  • Anatomy that precludes safe access to the tympanic membrane and safe use of the Solo+ TTD
  • Narrow ear canals
  • Congenital or craniofacial abnormalities affecting the ear
  • No baseline audiometry or tympanometry
  • Familial history of insensitivity to anesthetic components
  • Patient unable to remain still or is unsuitable for protective stabilization to undergo an in-office procedure

结局指标

主要结局

Rate of Adverse Events

时间窗: 24 months

Incidence and nature of device- or procedure-related adverse events

Procedure Success

时间窗: Intra-operative

Percentage of subjects in which the Solo+ TTD tympanostomy tube is inserted in all indicated ears

次要结局

未报告次要终点

研究者

发起方
AventaMed DAC
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

In-Office Clinical Study of the Solo+ TTD | 临床试验